Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Third Opinion: Discussing the results of the CONFIRM-HF (NCT01453608) of Daiichi Sankyo's recently approved INJECTAFER for patients with chronic heart failure and iron deficiency.

Ticker(s): DSKYF

Who's the expert?

Director, Heart & Vascular Center
20-24 patients with ATTR amyloidosis
Aware of PRONTO study (investigational drug phase II), drug trial vutrisiran, isatuximab, epidemiology study with patrisiran, and a PET/MR study for diagnosis.

Interview Goal

To discuss the current standard of care for iron deficiency associated with heart failure and the potential of Daiichi Sankyo's recently approved INJECTAFER, a ferric carboxymaltose injection for the treatment of iron deficiency in adult patients with heart failure.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.